Drug Clinical Trials List

Share page

Display 601 - 610 from 730
Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Registry of treatment patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) with progression during or after DOCETAXEL-based regimen Sanofi Ongoing N/A 4 DRIEG_C_05756 King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
Effect of ACS Patients' Education on Adherence to Dual Anti-platelet Therapy (unstable angina + non ST elevation MI + ST elevation MI) Sanofi Ongoing N/A 4 DIREG_L_05229 Dr. Soliman Fakeeh Hospital (Jeddah)
An observational Study to evaluate the behaviour of physicians focusing on the preference patterns (reasons to prescribe) of ARB/HCTZ combinations containing high dose (25mg) diuretic for treatment of hypertension in Saudi Arabia Sanofi Ongoing N/A 4 IRBEH_L_05674 King Khalid University Hospital (Riyadh)
Study of clinical and non clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice Sanofi Ongoing Lantus®/Apidra® 4 LANTUR06314 Dr. Erfan & Bagedo General Hospital (Jeddah)
Phase IV, Multicenter, International, Non-comparative, Open Label Study of Efficacy and Safety of Basal Bolus Therapy (Insulin Glargine + Insulin Glulisine) in Patients With T1 Diabetes Previously Uncontrolled on Any Insulin Regimen. Sanofi Ongoing Lantus® + Apidra® 4 LANTU_R_05033 King Khalid University Hospital (Riyadh)
multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in chronic kidney disease 4, 5 & 5D Sanofi Ongoing N/A 4 OBS13593 Saudi center for organ transplantation (Riyadh), King Fahad Hospital (Jeddah)
Registry on the use of Lactic acid (Lactacyd) in minor gynecologyical conditions among Middle Eastren women Sanofi Ongoing LACTOSERUM LACTIC ACID 4 LACACL06308 Dr. Erfan & Bagedo General Hospital (Jeddah)
An Observational, Cross-sectional Study on the Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in adult Population within the MENA Region. GSK Ongoing N/A 4 Version 2.1 - 30/08/2009 Prince Sultan Military Medical City (Riyadh)
Clinical Outcomes on ErbB2+ MBC Patients Treated With Lapatinib-Capecitabine After Trastuzumab Progression: Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO) GSK Ongoing Lapatinib / Capecitabine 4 113780 King Abdulaziz Medical City NG (Riyadh) , King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Hospital and Oncology Center (Jeddah)
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 Roche Ongoing Pegasys 3 ML22728 King Abdulaziz Medical City NG (Riyadh)


هل استفدت من ما هو مقدم في هذه الصفحة؟
0 من الزوار ردوا بنعم من أصل0 مشاركة
السبب
السبب